Back
Monte Rosa Therapeutics 10K Form
Sell
34
GLUE
Monte Rosa Therapeutics
Last Price:
8.49
Seasonality Move:
-8.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GLUE News And Ratings
See the #1 stock for the next 7 days that we like better than GLUE
GLUE Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-29.79M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.66 |
| Price / Book: | 2.49 |
Profitability
| EPS (TTM): | -2.24000 |
|---|---|
| Net Income (TTM): | $-130.41M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Monte Rosa Therapeutics Earnings Forecast
Key Monte Rosa Therapeutics Financial Ratios
- The Interest Expense is -0.01% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Monte Rosa Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GLUE |
| Website: | monterosatx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.56 |
| Quick Ratio: | 6.42 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
GLUE Technical Analysis vs Fundamental Analysis
Sell
34
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics a Buy or a Sell?
-
Monte Rosa Therapeutics stock is rated a Sell
The current Monte Rosa Therapeutics [GLUE] share price is $8.63. The Score for GLUE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.